Bram Piersma, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
Address513 Parnassus Ave
San Francisco CA 94143
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Piersma B, Wouters OY, Bank RA. aII-spectrin and ßII-spectrin do not affect TGFß1-induced myofibroblast differentiation. Cell Tissue Res. 2018 May 03. PMID: 29725768.
      View in: PubMed
    2. Piersma B, Wouters OY, de Rond S, Boersema M, Gjaltema RAF, Bank RA. Ascorbic acid promotes a TGFß1-induced myofibroblast phenotype switch. Physiol Rep. 2017 Sep; 5(17). PMID: 28904079.
      View in: PubMed
    3. Piersma B, Bank RA. Keeping fibroblasts in suspense: TAZ-mediated signaling activates a context-dependent profibrotic phenotype. Focus on "TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression". Am J Physiol Cell Physiol. 2017 Mar 01; 312(3):C274-C276. PMID: 28052865.
      View in: PubMed
    4. Piersma B, de Rond S, Werker PM, Boo S, Hinz B, van Beuge MM, Bank RA. YAP1 Is a Driver of Myofibroblast Differentiation in Normal and Diseased Fibroblasts. Am J Pathol. 2015 Dec; 185(12):3326-37. PMID: 26458763.
      View in: PubMed
    5. Piersma B, Bank RA, Boersema M. Signaling in Fibrosis: TGF-ß, WNT, and YAP/TAZ Converge. Front Med (Lausanne). 2015; 2:59. PMID: 26389119; PMCID: PMC4558529.